Otsuka Holdings Co., Ltd. (TYO:4578)

Market Cap	3.86T
Revenue (ttm)	2.33T
Net Income (ttm)	343.12B
Shares Out	537.09M
EPS (ttm)	633.77
PE Ratio	11.35
Forward PE	13.47
Dividend	120.00 (1.67%)
Ex-Dividend Date	Dec 27, 2024

Volume	1,088,800
Average Volume	1,120,920
Open	7,207.00
Previous Close	7,132.00
Day's Range	7,163.00 - 7,298.00
52-Week Range	5,683.00 - 9,669.00
Beta	0.19
RSI	32.52
Earnings Date	Feb 14, 2025

About Otsuka Holdings

Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. It also provides clinical testing, medical equipment, food products, cosmetics, functional food products, chemical products, soft drinks, beverages, analytical and measurement instruments, nutr...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1921
• Employees: 34,388
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4578

Financial Performance

In 2024, Otsuka Holdings's revenue was 2.33 trillion, an increase of 15.42% compared to the previous year's 2.02 trillion. Earnings were 343.12 billion, an increase of 182.13%.